642 related articles for article (PubMed ID: 32962164)
21. Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain.
You Y; Muraoka S; Jedrychowski MP; Hu J; McQuade AK; Young-Pearse T; Aslebagh R; Shaffer SA; Gygi SP; Blurton-Jones M; Poon WW; Ikezu T
J Extracell Vesicles; 2022 Jan; 11(1):e12183. PubMed ID: 35029059
[TBL] [Abstract][Full Text] [Related]
22. Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications.
Essayan-Perez S; Zhou B; Nabet AM; Wernig M; Huang YA
Neurobiol Dis; 2019 Oct; 130():104503. PubMed ID: 31202913
[TBL] [Abstract][Full Text] [Related]
23. Pushing the boundaries of brain organoids to study Alzheimer's disease.
Cerneckis J; Bu G; Shi Y
Trends Mol Med; 2023 Aug; 29(8):659-672. PubMed ID: 37353408
[TBL] [Abstract][Full Text] [Related]
24. Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells.
Yan Y; Song L; Bejoy J; Zhao J; Kanekiyo T; Bu G; Zhou Y; Li Y
Tissue Eng Part A; 2018 Jul; 24(13-14):1125-1137. PubMed ID: 29361890
[TBL] [Abstract][Full Text] [Related]
25. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.
Ooi L; Sidhu K; Poljak A; Sutherland G; O'Connor MD; Sachdev P; Münch G
J Neural Transm (Vienna); 2013 Jan; 120(1):103-11. PubMed ID: 22695755
[TBL] [Abstract][Full Text] [Related]
27. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
28. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
29. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
Mungenast AE; Siegert S; Tsai LH
Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
[TBL] [Abstract][Full Text] [Related]
30. Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format.
Medda X; Mertens L; Versweyveld S; Diels A; Barnham L; Bretteville A; Buist A; Verheyen A; Royaux I; Ebneth A; Cabrera-Socorro A
J Biomol Screen; 2016 Sep; 21(8):804-15. PubMed ID: 26984927
[TBL] [Abstract][Full Text] [Related]
31. Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons.
Berry BJ; Smith AST; Long CJ; Martin CC; Hickman JJ
ACS Chem Neurosci; 2018 Jul; 9(7):1693-1701. PubMed ID: 29746089
[TBL] [Abstract][Full Text] [Related]
32. Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer's Disease.
Wuli W; Tsai ST; Chiou TW; Harn HJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079110
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons.
van der Kant R; Langness VF; Herrera CM; Williams DA; Fong LK; Leestemaker Y; Steenvoorden E; Rynearson KD; Brouwers JF; Helms JB; Ovaa H; Giera M; Wagner SL; Bang AG; Goldstein LSB
Cell Stem Cell; 2019 Mar; 24(3):363-375.e9. PubMed ID: 30686764
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's in 3D culture: challenges and perspectives.
D'Avanzo C; Aronson J; Kim YH; Choi SH; Tanzi RE; Kim DY
Bioessays; 2015 Oct; 37(10):1139-48. PubMed ID: 26252541
[TBL] [Abstract][Full Text] [Related]
35. Cardiolipin released by microglia can act on neighboring glial cells to facilitate the uptake of amyloid-β (1-42).
Wenzel TJ; Murray TE; Noyovitz B; Narayana K; Gray TE; Le J; He J; Simtchouk S; Gibon J; Alcorn J; Mousseau DD; Zandberg WF; Klegeris A
Mol Cell Neurosci; 2023 Mar; 124():103804. PubMed ID: 36592800
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease.
Kwak SS; Washicosky KJ; Brand E; von Maydell D; Aronson J; Kim S; Capen DE; Cetinbas M; Sadreyev R; Ning S; Bylykbashi E; Xia W; Wagner SL; Choi SH; Tanzi RE; Kim DY
Nat Commun; 2020 Mar; 11(1):1377. PubMed ID: 32170138
[TBL] [Abstract][Full Text] [Related]
37. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
[
